Showing results (4191-4200 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|September 1, 2016
Evaluation of the characteristics of hepatic focal nodular hyperplasia: correlation between dynamic contrast-enhanced multislice computed tomography and pathological findingsHai-Tao Zhang, Xin-Yi Gao, Qin-Sha Xu, et al.Oncotargets and Therapy|May 12, 2017
Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case reportYanmei Peng, Huijuan Cui, Zhe Liu, et al.Oncotargets and Therapy|August 25, 2016
Network analysis reveals potential markers for pediatric adrenocortical carcinomaAnurag Kulshrestha, Shikha Suman, Rakesh RanjanOncotargets and Therapy|August 25, 2016
Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patientsWen-Kai Xia, Qing-Feng Lin, Dong Shen, et al.Oncotargets and Therapy|August 25, 2016
The impact of the extent of surgical resection on survival of gastric cancer patientsKostadin Georgiev Angelov, Mariela Borisova Vasileva, Konstantin Savov Grozdev, et al.Oncotargets and Therapy|August 27, 2016
Clinical implications of transforming growth factor-beta-induced gene-h3 protein expression in lung cancerChangjun He, Dawei Sun, Xue Bai, et al.Oncotargets and Therapy|April 27, 2017
Gastric cancer, nutritional status, and outcomeXuechao Liu, Haibo Qiu, Pengfei Kong, et al.Oncotargets and Therapy|May 9, 2017
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIsYang Liu, Li Sun, Zhi-Cheng Xiong, et al.Oncotargets and Therapy|May 13, 2017
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentinYong Hu, Jialan Zang, Xiaobing Qin, et al.Pageof 674